These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8548592)
21. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma. Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540 [TBL] [Abstract][Full Text] [Related]
22. Ewing's sarcoma of the pelvis. Long-term survival and functional outcome. Sucato DJ; Rougraff B; McGrath BE; Sizinski J; Davis M; Papandonatos G; Green D; Szarzanowicz T; Mindell ER Clin Orthop Relat Res; 2000 Apr; (373):193-201. PubMed ID: 10810477 [TBL] [Abstract][Full Text] [Related]
23. Primary Ewing's sarcoma-primitive neuroectodermal tumor of the vagina. Liao X; Xin X; Lü X Gynecol Oncol; 2004 Feb; 92(2):684-8. PubMed ID: 14766267 [TBL] [Abstract][Full Text] [Related]
24. [Ewing's sarcoma and related conditions]. Franchi A Pathologica; 2000 Apr; 92(2):123-5. PubMed ID: 10838882 [No Abstract] [Full Text] [Related]
27. Assessment of muscarinic and nicotinic acetylcholine receptor expression in primitive neuroectodermal tumor/ewing family of tumor and desmoplastic small round cell tumor: an immunohistochemical and Western blot study of tissue microarray and cell lines. Schlauder SM; Steffensen TS; Morgan M; Letson DG; Pledger WJ; Ma L; Bui MM Fetal Pediatr Pathol; 2008; 27(2):83-97. PubMed ID: 18568996 [TBL] [Abstract][Full Text] [Related]
28. Role of surgery in local treatment of Ewing's sarcoma of the extremities in patients undergoing adjuvant and neoadjuvant chemotherapy. Bacci G; Ferrari S; Longhi A; Donati D; Barbieri E; Forni C; Bertoni F; Manfrini M; Giacomini S; Bacchini P Oncol Rep; 2004 Jan; 11(1):111-20. PubMed ID: 14654912 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis. Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586 [TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications. Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539 [TBL] [Abstract][Full Text] [Related]
31. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028 [TBL] [Abstract][Full Text] [Related]
32. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. Thorner P; Squire J; Chilton-MacNeil S; Marrano P; Bayani J; Malkin D; Greenberg M; Lorenzana A; Zielenska M Am J Pathol; 1996 Apr; 148(4):1125-38. PubMed ID: 8644855 [TBL] [Abstract][Full Text] [Related]
37. [Tumors of the Ewing/PNET sarcoma family]. Pettinato G Pathologica; 2003 Oct; 95(5):241-2. PubMed ID: 14988992 [No Abstract] [Full Text] [Related]
38. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184 [TBL] [Abstract][Full Text] [Related]
39. New approaches in the diagnosis of small-cell round tumors of bone and soft tissue. Petrov SV; Machado I; Boulytcheva IV; Noguera R; Pellin A; Bacchini P; Bertoni F; Llombart-Bosch A Arkh Patol; 2009; 71(1):34-40. PubMed ID: 19514357 [TBL] [Abstract][Full Text] [Related]
40. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein. Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]